Targeting Alpha-Synuclein: Breakthroughs in the Quest to Halt Parkinson's Progression

New clues to the development of Parkinson's disease: Copper leads to protein aggregation - Suspicious metal

New hopes for disease modification in Parkinson's Disease - ScienceDirect

IJMS, Free Full-Text

PDF) Alpha synuclein post translational modifications: potential targets for Parkinson's disease therapy?

Pharmaceutics, Free Full-Text

Neuronal haemoglobin induces loss of dopaminergic neurons in mouse Substantia nigra, cognitive deficits and cleavage of endogenous α-synuclein

Frontiers Parkinson's Disease: A Nanotheranostic Approach Targeting Alpha- Synuclein Aggregation

A Peptide Approach to Reducing alpha-Synuclein in Parkinson's Disease

Pharmaceutics, Free Full-Text

PDF] The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson's Disease

New hopes for disease modification in Parkinson's Disease - ScienceDirect

IJMS, Free Full-Text

Alpha-Synuclein: Biomarker for Parkinson's Disease, It's Estimation Methods, and Targeted Medicinal Therapies